Companies to present at TC Cowen 45th Annual Health Care Conference
Apellis Pharmaceuticals and EyePoint Pharmaceuticals are both scheduled to present at the conference.
(Image credit: AdobeStock/kasto)
Two pharmaceuticals companies that are currently developing ophthalmic treatment candidates are set to present at the TC Cowen 45th Annual Health Care Conference. This meeting will take place in Boston, Massachusetts from March 3-5, 2025.
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. is scheduled to present on the first day of the conference, Monday, March 3, 2025. The presentation will take place at 10:30 am ET.
The company has shared that the live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. According to the press release, a replay of the webcast will be available for approximately 90 days following the event.
EyePoint Pharmaceuticals, Inc.
Jay S. Duker, MD, EyePoint’s President and CEO, will present an update on enrollment for its ongoing Phase 3 pivotal program of DURAVYU in wet age-related macular degeneration (wet AMD) and additional subgroup analyses for the Phase 2 VERONA trial for DURAVYU in diabetic macular edema (DME) during the conference. This presentation is scheduled for Tuesday, March 4, 2025 at 9:10 am ET.
